Integral Diagnostics: Integral Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023

Integral Diagnostics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 231.25 million compared to AUD 215.7 million a... Integral Diagnostics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 231.25 million compared to AUD 215.7 million a year ago. Revenue was AUD 231.63 million compared to AUD 215.95 million a year ago. Net loss was AUD 66.76 million compared to net income of AUD 16.14 million a year ago. Basic loss per share from continuing operations was AUD 0.2862 compared to basic earnings per share from continuing operations of AUD 0.0694 a year ago. Diluted loss per share from continuing operations was AUD 0.2862 compared to diluted earnings per share from continuing operations of AUD 0.0685 a year ago.